BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 34010698)

  • 1. Home epinephrine-treated reactions in food allergy oral immunotherapy: Lessons from the coronavirus disease 2019 lockdown.
    Nachshon L; Goldberg MR; Levy MB; Epstein-Rigbi N; Koren Y; Elizur A
    Ann Allergy Asthma Immunol; 2021 Oct; 127(4):451-455.e1. PubMed ID: 34010698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Characteristics and Risk Factors for Home Epinephrine-Treated Reactions During Oral Immunotherapy for Food Allergy.
    Nachshon L; Schwartz N; Tsviban L; Levy MB; Goldberg MR; Epstein-Rigby N; Katz Y; Elizur A
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):185-192.e3. PubMed ID: 32750430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triggers for Home Epinephrine-Treated Reactions During Oral Immunotherapy for Food Allergy.
    Nachshon L; Levy MB; Goldberg MR; Epstein-Rigbi N; Schwartz N; Katz Y; Elizur A
    J Allergy Clin Immunol Pract; 2022 Apr; 10(4):1070-1076.e2. PubMed ID: 34982978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe Anaphylactic Reactions to Home Doses of Oral Immunotherapy for Food Allergy.
    Nachshon L; Schwartz N; Levy MB; Goldberg M; Epstein-Rigbi N; Katz Y; Elizur A
    J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2524-2533.e3. PubMed ID: 36925102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of food allergy oral immunotherapy in adults.
    Epstein-Rigbi N; Levy MB; Nachshon L; Koren Y; Katz Y; Goldberg MR; Elizur A
    Allergy; 2023 Mar; 78(3):803-811. PubMed ID: 36190349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with home epinephrine-treated reactions during peanut and tree-nut oral immunotherapy.
    Nachshon L; Schwartz N; Levy MB; Goldberg MR; Epstein-Rigbi N; Katz Y; Elizur A
    Ann Allergy Asthma Immunol; 2023 Mar; 130(3):340-346.e5. PubMed ID: 36509409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Effectiveness of Bypassing Oral Immunotherapy Buildup With an Initial Phase of Sublingual Immunotherapy for Higher-Risk Food Allergy.
    Soller L; Williams BA; Mak R; Wong T; Erdle SC; Chomyn A; Tetreault B; Morrison K; Gaudet L; Chan ES
    J Allergy Clin Immunol Pract; 2024 May; 12(5):1283-1296.e2. PubMed ID: 38423293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergen-specific oral immunotherapy for peanut allergy.
    Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
    Cochrane Database Syst Rev; 2012 Sep; (9):CD009014. PubMed ID: 22972130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse effects during specific oral tolerance induction: in home phase.
    Barbi E; Longo G; Berti I; Matarazzo L; Rubert L; Saccari A; Lenisa I; Ronfani L; Radillo O; Ventura A
    Allergol Immunopathol (Madr); 2012; 40(1):41-50. PubMed ID: 21802824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Sesame Oral Immunotherapy-A Real-World, Single-Center Study.
    Nachshon L; Goldberg MR; Levy MB; Appel MY; Epstein-Rigbi N; Lidholm J; Holmqvist M; Katz Y; Elizur A
    J Allergy Clin Immunol Pract; 2019; 7(8):2775-2781.e2. PubMed ID: 31150789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.
    Wasserman RL; Factor JM; Baker JW; Mansfield LE; Katz Y; Hague AR; Paul MM; Sugerman RW; Lee JO; Lester MR; Mendelson LM; Nacshon L; Levy MB; Goldberg MR; Elizur A
    J Allergy Clin Immunol Pract; 2014; 2(1):91-6. PubMed ID: 24565775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of Multifood Oral Immunotherapy in Children Aged 1 to 18 Years at an Academic Pediatric Clinic.
    Nguyen K; Lewis MO; Hanna E; Alfaro MKC; Corrigan K; Buonanno J; Datta R; Brown-Whitehorn T; Spergel JM; Cianferoni A
    J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1907-1913.e1. PubMed ID: 36907355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for discontinuing oral immunotherapy in children with persistent cow milk allergy.
    Benelli E; Trombetta A; Badina L; Andrade S; Zamagni G; Prisco A; Traini E; Barbi E; Berti I
    Immun Inflamm Dis; 2022 Jul; 10(7):e668. PubMed ID: 35759227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient quality of life following induction of oral immunotherapy for food allergy.
    Epstein Rigbi N; Katz Y; Goldberg MR; Levy MB; Nachshon L; Elizur A
    Pediatr Allergy Immunol; 2016 May; 27(3):263-8. PubMed ID: 26681071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter, randomized, double-blind, placebo-controlled clinical trial of vital wheat gluten oral immunotherapy.
    Nowak-Węgrzyn A; Wood RA; Nadeau KC; Pongracic JA; Henning AK; Lindblad RW; Beyer K; Sampson HA
    J Allergy Clin Immunol; 2019 Feb; 143(2):651-661.e9. PubMed ID: 30389226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-Center Noninferiority Randomized Trial on the Efficacy and Safety of Low- and High-Dose Rush Oral Milk Immunotherapy for Severe Milk Allergy.
    Takaoka Y; Yajima Y; Ito YM; Kumon J; Muroya T; Tsurinaga Y; Shigekawa A; Takahashi S; Iba N; Tsuji T; Nishikido T; Yoshida Y; Doi S; Kameda M
    Int Arch Allergy Immunol; 2020; 181(9):699-705. PubMed ID: 32570237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral immunotherapy for multiple foods in a pediatric allergy clinic setting.
    Eapen AA; Lavery WJ; Siddiqui JS; Lierl MB
    Ann Allergy Asthma Immunol; 2019 Dec; 123(6):573-581.e3. PubMed ID: 31494236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Immunotherapy for Food Allergy: A Spanish Guideline. Egg and Milk Immunotherapy Spanish Guide (ITEMS GUIDE). Part II: Maintenance Phase of Cow Milk (CM) and Egg Oral Immunotherapy (OIT), Special Treatment Dosing Schedules. Models of Dosing Schedules of OIT With CM and Egg.
    Martorell A; Alonso E; Echeverría L; Escudero C; García-Rodríguez R; Blasco C; Bone J; Borja-Segade J; Bracamonte T; Claver A; Corzo JL; De la Hoz B; Del Olmo R; Dominguez O; Fuentes-Aparicio V; Guallar I; Larramona H; Martín-Muñoz F; Matheu V; Michavila A; Ojeda I; Ojeda P; Piquer M; Poza P; Reche M; Rodríguez Del Río P; Rodríguez M; Ruano F; Sánchez-García S; Terrados S; Valdesoiro L; Vazquez-Ortiz M;
    J Investig Allergol Clin Immunol; 2017; 27(5):279-290. PubMed ID: 28593864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-life experience with hazelnut oral immunotherapy.
    Sabouraud M; Biermé P; André-Gomez SA; Villard-Truc F; Payot F; Corréard AK; Garnier L; Braun C
    Ann Allergy Asthma Immunol; 2022 Apr; 128(4):432-438. PubMed ID: 35007745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is oral immunotherapy the cure for food allergies?
    Nowak-Wegrzyn A; Fiocchi A
    Curr Opin Allergy Clin Immunol; 2010 Jun; 10(3):214-9. PubMed ID: 20431369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.